The 49 references in paper A. Danilenko A., S. Shakhtarina V., А. Даниленко А., С. Шахтарина В. (2014) “Ранние и поздние легочные осложнения лучевой терапии лимфомы Ходжкина // Early and long-term pulmonary complications of radiotherapy of Hodgkin's lymphoma” / spz:neicon:pulmonology:y:2013:i:6:p:92-98

1
Williams J.P., Johnston C.J., Finkelstein J.N.Treatment for radiation-induced pulmonary late effects: Spoiled for choice or looking in the wrong direction? Curr. Drug Targets 2010; 11 (11): 1386–1394.
(check this in PDF content)
2
Notter R.H., Finkelstein J.N., Holm B.A.Lung injury: mechanisms, pathophysiology, and therapy. New York: Taylor & Fransis, 2005.
(check this in PDF content)
3
Bentzen S.M.Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nature Rev. Cancer. 2006; 6: 702–713.
(check this in PDF content)
4
Mikkelsen R.B., Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 2003; 22: 5734–5754.
(check this in PDF content)
5
Fleckenstein K., Zgonjanin L., Chen L. et al.Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2007; 68: 196–204.
(check this in PDF content)
6
Ghafoori P., Marks L.B., Vujaskovic Z. et al.Radiationinduced lung injury: assessment, management, and prevention. Oncology 2008; 22 (1): 37–47.
(check this in PDF content)
7
Young B., Lowe J.S., Stevens A., Heath J.W. Wheather′s functional histology: a text and colour atlas. 5rd ed. London: Churchill Livingstone, 2006.
(check this in PDF content)
8
Rubin P., Shapiro D.L., Finklestein J.N. et al. The early release of surfactant following lung irradiation of alveolar type II cells. Int. J. Radiat. Oncol. Biol. Phys.1980; 6: 75–77.
(check this in PDF content)
9
Allavena C., Conroy T., Aletti P. et al.Late cardiopulmonary toxicity after treatment for Hodgkin′s disease. Br. J. Cancer 1992; 65: 908–912.
(check this in PDF content)
10
Torrisi J.M., Schwartz L.H., Gollub M.J. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology 2011; 258 (1): 41–56.
(check this in PDF content)
11
Трахтенберг А.Х., Чиссов В.И. Клиническая онкопульмонология. М.: ГЭОТАР Медицина, 2000.
(check this in PDF content)
12
Marks L.B., Fan M., Clough R. et al. Radiation-induced pulmonary injury: Symptomatic versus subclinical endpoints. Int. J. Radiat. Biol. 2000; 76: 469–475. Даниленко А.А., Шахтарина С.В. Ранние и поздние легочные осложнения лучевой терапии лимфомы Ходжкина Обзоры
(check this in PDF content)
13
Goethals I., Dierckx R., Meerleer G. et al.The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage. J. Nucl. Med. 2003; 44 (9): 1531–1539.
(check this in PDF content)
14
Bria W.F., Kanarek D.J., Kazemi H. Prediction of postoperative pulmonary function following thoracic operations: value of ventilation-perfusion scanning. J. Thorac. Cardiovasc. Surg.1983; 86: 186–192.
(check this in PDF content)
15
Rubenstein J., Richter M., Moldofsky P. et al. Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing. Int. J. Radiat. Oncol. Biol. Phys.1988; 15: 83–87.
(check this in PDF content)
16
Choi N., Kanarek D., Grillo H. Effect of post-operative radiotherapy on changes in pulmonary function in patients with stage II and IIIa lung carcinoma. Int. J. Radiat. Oncol. Biol. Phys.1990; 18: 95–99.
(check this in PDF content)
17
Curran W., Moldofsky P., Solin L. Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma. Int. J. Radiat. Oncol. Biol. Phys.1992; 24: 31–36.
(check this in PDF content)
18
Boersma L., Damen.E., de Boer R. et al. A new method to determine dose-effect relations for local lung function changes using correlated SPECT and CT data. Radiother. Oncol.1993; 29: 110–116.
(check this in PDF content)
19
Boersma L., Damen E., de Boer R.W. et al.Estimation of overall pulmonary function after irradiation using doseeffect relations for local functional injury. Radiother. Oncol. 1995; 36: 15–23.
(check this in PDF content)
20
Boersma L., Damen E., de Boer R.W. et al. Recovery of overall and local function loss 18 monthsafter irradiation for malignant lymphoma. J. Clin. Oncol.1996; 14: 1431–1441.
(check this in PDF content)
21
Theuws J., Kwa S., Wagenaar A. et al.Prediction of overall pulmonary function loss in relation to 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother. Oncol. 1998; 49: 233–243.
(check this in PDF content)
22
Robnett T.J., Machtay M., Vines E.P. et al.Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int. J. Radiat. Oncol. Biol. Phys.2000; 48: 89–94.
(check this in PDF content)
23
Kim T.H., Cho K.H., Pyo H.R. et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimentional conformal radiation therapy for lung cancer. Radiology 2005; 235: 208–215.
(check this in PDF content)
24
Kong F.M., Haymann J.A., Griffith K.A. et al.Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 2006; 65: 1075–1086.
(check this in PDF content)
25
Hua C., Hoth K.A., Wu S. et al.Incidence and correlates of radiation pneumonitis in pediatric patients with partial lung irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2012; 78 (1): 43–149.
(check this in PDF content)
26
Fox A.M., Dosoretz A.P., Mauch P.M. et al. Predictive factors for radiation pneumonitis in Hodgkin is lymphoma patients receiving combined modality therapy. Int. J. Radiat. Oncol. Biol. Phys. 2012; 83 (1): 277–283.
(check this in PDF content)
27
Koh E.S., Sun A., Tran T.H. et al.Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin′s lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 2006; 66 (1): 223–228.
(check this in PDF content)
28
Meadors M., Floyd J., Perry M.C. Pulmonary toxicity of chemotherapy. Semin. Oncol. 2006; 33: 98–105.
(check this in PDF content)
29
Байсоголов Г.Д., Афанасова Н.В., Шахтарина С.В. и др. Изменения в легких у больных лимфогранулематозом I–II клинической стадии после комбинированного лечения. Мед. радиол. 1985; 3: 18–22.
(check this in PDF content)
30
Hirsch A., Van der Els N., Straus D.J. et al. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin`s disease. J. Clin. Oncol. 1996; 14: 1297–1305.
(check this in PDF content)
31
Macann A., Bredenfeld H., Muller R.P. et al. Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin′s lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin′s Lymphoma Study Group. Int. J. Radiat. Oncol. Biol. Phys. 2008; 70 (1): 161–165.
(check this in PDF content)
32
Бардычев М.С., Цыб А.Ф. Местные лучевые повреждения. М.: Медицина, 1985.
(check this in PDF content)
33
Park K.J., Chung J.Y., Chun M.S. et al.Radiation-induced lung disease and the impact of radiation methods on imaging features. Radiographics 2000; 20 (1): 83–98.
(check this in PDF content)
34
Abratt R., Morgan G. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 2002; 35: 103–109.
(check this in PDF content)
35
Rubin P., Finkelstein J., Shapiro D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblasts. Int. J. Radiat. Oncol. Biol. Phys. 1992; 24: 93–101.
(check this in PDF content)
36
Коврыжкина Т.А., Ильин Н.В., Акимов А.А. и др. Использование линейно-квадратичной модели для оценки поздних лучевых повреждений легких у больных лимфогранулематозом. Мед. радиол. 1997; 3: 59–63.
(check this in PDF content)
37
Villani F., Busia A., Villani M. et al. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin′s disease. Anticancer Res. 2009; 29 (2): 777–784.
(check this in PDF content)
38
Lund M.B., Kongerud J., Boe J. et al.Late complications after treatment of Hodgkin`s disease. Tidsskr. Norske Laegeforen. 1999; 119 (7): 933–937.
(check this in PDF content)
39
Enrichi R.M., Anselmo A.P., Donato V. et al.Relapse and late complications in early-stage Hodgkin′s disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD. Haematologica 1999; 84 (10): 17–23.
(check this in PDF content)
40
Brusamolino E., Baio A., Orlandi E. et al. Long-term events in adult patients with clinical stage IA–IIA nonbulky Hodgkin`s lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. Clin. Cancer Res. 2006; 12 (21): 6487–6493.
(check this in PDF content)
41
Andrieu J.M., Jais J.P., Colonna P. et al.Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin′s disease at advanced stages. Ann. Oncol. 1998; 9 (2): 195–203.
(check this in PDF content)
42
Даниленко А.А., Шахтарина С.В., Афанасова Н.В., Пав7 лов В.В. Изменения в легких у больных лимфомой Ходжкина после химиотерапии по схемам СОРР, ABVD, BEACOPP и облучения средостения в суммарной очаговой дозе 20–30 Гр. Клин. онкогематол. 2010; 3 (4): 354–358.
(check this in PDF content)
43
Sasse A.D., Clark L.G., Sasse E.C., Clark O.A. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int. J. Radiat. Oncol. Biol. Phys. 2006; 64: 784–791.
(check this in PDF content)
44
Levi M., Knol J.A., Ensminger W.D. et al.Regional pharmacokinetics of amifostine in anesthetized dogs: role of the liver, gastrointestinal tract, lungs, and kidneys. Drug Metabol. Disposit. 2002; 30: 1425–1430. Даниленко А.А., Шахтарина С.В. Ранние и поздние легочные осложнения лучевой терапии лимфомы Ходжкина
(check this in PDF content)
45
Greenberg J.S., Epperly M.W. Antioxidant gene therapeutic approaches to normal tissue protection and tumor radiosensitization. In Vitro 2007; 21: 141–146.
(check this in PDF content)
46
Gauter7Fleckenstein B., Fleckenstein K., Owzar K. et al. Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection. Free Radic. Biol. Med. 2008; 44: 982–989.
(check this in PDF content)
47
Williams J.P., Hernady E., Johnston C.J. et al.Effect of administration of lovastatin on the development of late pulmonary effects following whole lung irradiation in a murine model. Radiat. Res. 2004; 161: 560–567.
(check this in PDF content)
48
Xie C.H., Zhang M.S., Zhou Y.F. et al.Chinese medicine Angelica sinensis supresses radiation-induced expression of TNF-αand TGF-βin mice. Oncol. Rep. 2006; 15: 1429–1436.
(check this in PDF content)
49
Kozaka Y., Mitsumori M., Araki N. et al. Avascular necrosis of bilateral femoral head as a result of long-term steroid administration for radiation pneumonitis after tangential irradiation of the breast. Int. J. Clin. Oncol. 2006; 11: 482–486.
(check this in PDF content)